164. Bevacizumab Suppresses Neuroblastoma Progression in the Setting of Minimal Residual Disease von Sims, Thomas L, Hamner, J. Blair B, Ng, Cathy, Rosati, Shannon F, Spence, Yunyu H, Williams, Regan F, Davidoff, Andrew M

Volltext